PGNX - Progenics Pharmaceuticals EPS beats by $0.04 misses on revenue November, 07 2019 08:10 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q3 GAAP EPS of -$0.22 beats by $0.04.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...